Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: Spain Clear all

222 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20044
20054
20069
20078
200810
20094
20104
20115
20124
20137
20148
201515
20169
20179
201811
20198
202016
202111
202214
202313
202418
202516
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed94
Active, not recruiting57
Recruiting40
Terminated30
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca25
Merck Sharp & Dohme LLC23
Hoffmann-La Roche21
Eli Lilly and Company14
Bristol-Myers Squibb13
Pfizer13
Novartis Pharmaceuticals10
Boehringer Ingelheim7
Daiichi Sankyo6
EMD Serono Research & Development Institute, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung222
Lung Neoplasms37
Neoplasm Metastasis13
Carcinoma11
Neoplasms11
Lung Diseases8
Carcinoma, Squamous Cell5
Respiratory Tract Neoplasms5
Carcinoma, Large Cell4
Thoracic Neoplasms4

Trials

Showing 1 to 25 of 222. Each trial links to its page on Pharma Observatory.

122 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.